Literature DB >> 35033989

First Report of Cerebral Venous Thrombosis Following Inactivated-Virus Covid Vaccination (Sinopharm and Sinovac).

Sajid Hameed1, Ayisha Farooq Khan1, Sara Khan1, Mohammad Wasay2.   

Abstract

Cerebral venous thrombosis (CVT) is an uncommon cerebrovascular disease, which has been reported with covid infection as well as covid vaccines, particularly AstraZeneca and Janssen vaccines. We present four consecutive cases of CVT after receiving either Sinopharm or Sinovac vaccine, both of which are composed of an inactivated-virus. All the patients recovered well with anticoagulation and discharged with a good functional outcome. This is the first case series reporting CVT following the administration of these vaccines.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CVT; Cerebral venous thrombosis; Sinopharm; Sinovac; Vaccine

Mesh:

Substances:

Year:  2022        PMID: 35033989     DOI: 10.1016/j.jstrokecerebrovasdis.2021.106298

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  2 in total

1.  Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series.

Authors:  Eric Yuk Fai Wan; Yuan Wang; Celine Sze Ling Chui; Anna Hoi Ying Mok; Wanchun Xu; Vincent Ka Chun Yan; Francisco Tsz Tsun Lai; Xue Li; Carlos King Ho Wong; Esther Wai Yin Chan; Kui Kai Lau; Benjamin John Cowling; Ivan Fan Ngai Hung; Ian Chi Kei Wong
Journal:  Lancet Healthy Longev       Date:  2022-07-04

2.  Inactivated COVID-19 vaccine induced acute stroke-like focal neurologic symptoms: a case series.

Authors:  Duangnapa Roongpiboonsopit; Chichaya Nithisathienchai; Wasan Akarathanawat; Krittanon Lertutsahakul; Jarturon Tantivattana; Anand Viswanathan; Nijasri Charnnarong Suwanwela
Journal:  BMC Neurol       Date:  2022-06-07       Impact factor: 2.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.